Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes
COVID · 24.12.2024 · 5 (1) · 2
DOI: 10.3390/covid5010002 ↗Kurz gefasst
Fachartikel in der Zeitschrift COVID, online erschienen am 24.12.2024. Verfasst von Olivia A Smith und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical Medicine, Medical Microbiology, and Pharmacology, University of Hawaii Manoa, Honolulu, HI 96813, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Hawaii Community Foundation, National Institute of Allergy and Infectious Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The emergence of SARS-CoV-2 has resulted in a significant impact on public health, particularly for individuals with underlying health conditions such as obesity and diabetes. While vaccination efforts have played a crucial role in reducing hospitalizations, it remains unclear whether the effectiveness of these vaccines varies among different population groups. In this study, we investigated the immune responses generated by various SARS-CoV-2 vaccine platforms in mouse models with obesity and diabetes, focusing on both cell-mediated and humoral immune responses. Our findings revealed diminished immune responses in diabetic and obese mice compared to healthy counterparts. After vaccination with adjuvanted subunit or mRNA lipid nanoparticle (LNP) vaccines, both humoral and cell-mediated responses were significantly reduced in diabetic mice. Obese mice also exhibited decreased immunogenicity, albeit to a lesser extent. However, it should be noted that mRNA vaccines demonstrated strong neutralizing responses across all metabolic states, while adjuvanted subunit vaccines elicited higher antibody avidity in mice with type 2 diabetes (T2D) and obesity compared to healthy mice. These results suggest that the impaired humoral and cell-mediated responses observed in altered metabolic states may be linked to chronic inflammation associated with obesity and suboptimal glycemic control in diabetes. Understanding the impact of these metabolic disturbances on vaccine immunogenicity is crucial for developing optimized vaccines that can effectively enhance immune responses and provide long-lasting protection against SARS-CoV-2, even in individuals with obesity and diabetes. By contributing these findings, we support efforts to improve vaccine efficacy in populations affected by metabolic disorders, advancing effective immunization against SARS-CoV-2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Tropical Medicine, Medical Microbiology, and Pharmacology, University of Hawaii Manoa, Honolulu, HI 96813, USA.
- Cell and Molecular Biology Graduate Program, University of Hawaii Manoa, Honolulu, HI 96813, USA.
- Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Acuitas Therapeutics, Vancouver, BC V6T 1Z3, Canada.
ORCID-Profile: Olivia A Smith, Brent Fujimoto, Teri Ann S Wong, Albert To, Hiromi Muramatsu, Ying K Tam, Norbert Pardi
Förderung
- NIAID NIH HHS
- Hawaii Community Foundation
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Smith, O. A., Fujimoto, B., Wong, T. A. S., To, A., Odo, T., Ball, A., Haun, B. K., Muramatsu, H., Tam, Y. K., Pardi, N., & Lehrer, A. T. (2024). Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes. COVID, 5(1), 2. https://doi.org/10.3390/covid5010002
Vancouver
Smith OA, Fujimoto B, Wong TAS, To A, Odo T, Ball A, et al. Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes. COVID. 2024;5(1):2. doi:10.3390/covid5010002
BibTeX
@article{Smith2024,
author = {Smith, Olivia A and Fujimoto, Brent and Wong, Teri Ann S and To, Albert and Odo, Troy and Ball, Aquena and Haun, Brien K and Muramatsu, Hiromi and Tam, Ying K and Pardi, Norbert and Lehrer, Axel T},
title = {Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes},
journal = {COVID},
year = {2024},
volume = {5},
number = {1},
pages = {2},
doi = {10.3390/covid5010002}
}
EUVIMED